Rupintrivir

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRupintrivir
Drug Alias Namerupintrivirum芦平曲韦RuprintrivirAG-7088
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionPicornain 3C protease inhibitors
TargetsPicornain 3C protease
Therapy Area/IndicationsRhinovirus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsRhinovirus infection

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG